Medicare in the New Year

BIG Changes Are On The Way for Medicare Part D Patients in 2024

By phasing out the Donut Hole next year, your out-of-pocket maximum will lower to $3,300 for brand and $8,000 for generic medications.

What does this mean for Medicare patients?

The changes for 2024 could create uncertainty for Medicare patients in free drug programs and it may involve being reevaluated to confirm qualification. Onco360 can help by connecting qualified patients to alternative funding sources now – and all year long.

If you have concerns about the cost of your medications, contact our OncoAdvocate® Team today at 877.662.6633. They are a dedicated team of over 30 associates who are experts at finding third-party funding solutions for qualified patients so they can start therapy quickly.

In 2023, 62% of our Medicare patients have ZERO out-of-pocket expenses
with a projected $525 million secured from third-party funding
by our OncoAdvocate® Team.

If you are approved for funding assistance, you are automatically enrolled in a one-of-a kind program that searches for available assistance multiple times a day. When your funding is available, you will be matched and notified quickly.

If you would like more information for the Medicare changes in 2024, please visit:

Why Choose Onco360 if You Have Medicare?

  • Timing is crucial when it comes to cancer treatment. Our goal, without prior authorization or funding issues, is to have your medication delivered within 3-4 days. We even provide complimentary overnight shipping to your doorstep.
  • As a specialty pharmacy 100% focused on cancer, we will act as your advocate with your physician, insurance company, and others involved in your treatment.
  • We will make sure you understand your medications, their dosage, and any potential side effects. Our clinicians and pharmacists are on call 24/7 if you have any issues at 877.662.6633.


If you are a provider and would like to refer to Onco360, click below

How to Refer